1. Home
  2. SXTP
  3. SXTP News

Latest 60 Degrees Pharmaceuticals Inc. (SXTP) News on July 18, 2024

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

GlobeNewswire

9 days ago

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

Business Wire

a month ago

Net Asset Value(s)

Associated Press Finance

8 months ago

Acorda: Q3 Earnings Snapshot

Share on Social Networks: